Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2005
08/11/2005WO2004089300A3 Sapphyrins and uses thereof
08/11/2005US20050176968 Process for producing indolopyrrolocarbazole derivative
08/11/2005US20050176957 reacting nicotinic acid derivatives with amidine derivatives to yield substituted pyridopyrimidones
08/11/2005US20050176801 Acyl bicyclic derivatives of pyrrol
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176754 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
08/11/2005US20050176748 Vinorelbine derivatives
08/11/2005US20050176737 Mitotic kinesin inhibitors
08/11/2005US20050176736 Made by reacting a 5-aminotriazole with a phenylmalonates to give dihydroxytriazolopyrimidines which is halogenated then aminated
08/11/2005US20050176735 For use as anxiolytic, antiepileptic, sedative-hypnotic agents and skeletal muscle relaxants
08/11/2005US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
08/11/2005US20050176715 Piperidine derivatives
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176683 Hexa-/Tetra-hydro-pyrrolo[1,2-a]imidazole-2,5-dione derivatives; solid phase synthesis
08/11/2005US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity
08/11/2005US20050175984 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device
08/11/2005US20050175856 Electroluminescent device
08/11/2005DE102004003888A1 Mesoionische Pigmente Mesoionic pigments
08/11/2005DE102004003791A1 Verwendung von Phthalocyaninen als Markierungsstoffe für Flüssigkeiten The use of phthalocyanines as markers for liquids
08/11/2005CA2554387A1 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/11/2005CA2551778A1 Imidazo[1,2-c]pyrimidinylacetic acid derivatives
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560832A1 Pyrimido 4,5-d pyrimidine derivatives with anticancer activity
08/10/2005EP1560831A1 Novel amino-substituted dihydropyrimido [4,5-d] pyrimidin one derivatives, their manufacture and use as pharmaceutical agents
08/10/2005EP1560830A2 Derivatives of [6, 7 - dihydro - 5h - imidazo [1,2 - a] imidazole - 3 - sulfonylamino]- propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
08/10/2005EP1560829A1 Pyrimido compounds having antiproliferative activity (ii)
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1560582A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
08/10/2005EP1373274B1 A process for synthesis of a porphyrin compound using a molecular sieve catalyst under microwave irradiation
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP0888301B1 Mcbi analogs of cc-1065 and the duocarmycins
08/10/2005CN2716267Y Equipment for synthesizing sildenafil
08/10/2005CN1653138A Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1214009C antibacterial composition
08/10/2005CN1213998C Processes and intermediates useful to make antifolates
08/10/2005CN1213754C Beta-carboline pharmaceutical compositions
08/09/2005US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
08/09/2005US6927221 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/04/2005WO2005071096A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
08/04/2005WO2005070935A1 Use of phthalocyanines as marking substances for liquids
08/04/2005WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
08/04/2005WO2005070933A1 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same
08/04/2005WO2005070932A2 Substituted heterocyclic compounds and methods of use
08/04/2005WO2005070931A1 Two-phase method for the synthesis of selected pyrazolopyrimidines
08/04/2005WO2005070928A1 2,4-dioxopyrimidine-based mesoionic pigments
08/04/2005WO2005070906A1 Organic compounds
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070431A1 Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
08/04/2005WO2005070415A1 Adjuvant compositions
08/04/2005WO2005069894A2 Conformationally constrained smac mimetics and the uses thereof
08/04/2005WO2005069865A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
08/04/2005WO2005058245A3 Synthetic process
08/04/2005WO2005051917B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/04/2005WO2005033048A3 Wnt pathway antagonists
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171349 Method for producing n-ethyl-n-{3-(3-cyanopyrazolo{1,5a}pyrimidine-7-yl)phenyl acetamide
08/04/2005US20050171345 Pteridine compounds for the treatment of psoriasis
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171181 Histamine-3 receptor modulators
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors
08/04/2005US20050171128 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171113 Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171110 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
08/04/2005US20050171108 Having 6-position substituent; sulfonylurea herbicides and intermediates; simple, low cost, high yield; transition metal catalytic reaction of leaving group with organometallic compound
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171094 Pyrrolopyrimidine derivatives
08/04/2005US20050171093 New piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutial compositions
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders
08/04/2005US20050167637 cycloquaterbenzoxazoles, cycloquaternaphthoxazoles, cycloquaterbenzimidazoles and cycloquaternaphthimidazoles, used in photoactive performance chemicals, such as charge generating compounds in organic light emitter diodes,as phase transfer catalysts, dispersants in pigments or optical recording media
08/04/2005US20050166335 4,5-diamino-1,2-dimethyl-1,2-dihydropyrazol-3-one; oxidation dyes for human hair
08/04/2005CA2554132A1 Use of phthalocyanines as marking substances for liquids
08/04/2005CA2553986A1 Adjuvant compositions
08/04/2005CA2553923A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2553874A1 Conformationally constrained smac mimetics and the uses thereof
08/04/2005CA2553465A1 Two-phase method for the synthesis of selected pyrazolopyrimidines
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2553009A1 Organic compounds
08/04/2005CA2552885A1 Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
08/04/2005CA2552388A1 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 573